Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04126850
Other study ID # 19-05-0624
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date November 1, 2019
Est. completion date July 30, 2020

Study information

Verified date October 2019
Source Fakultas Kedokteran Universitas Indonesia
Contact Ratna Sitompul, Professor
Phone +628118009911
Email ratna_sitompul@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aimed to discover the composition on the microbiome in several sites of the human body; and to find out the difference in microbiome composition on ocular fluid, blood, and feces before and after therapy in uveitis patient with history of autoimmune disease (Behcet and Vogt-Koyanagi-Harada) and idiopathic uveitis


Description:

Gut microbiome has been widely studied around the globe, and it is convinced that the gut microbiome plays an essential role in many human diseases. In a published review showed the presence of microbes in blood from a patient who suffered from non-communicable disease. The microbes present in dormant or not-immediately-culturable states as if blood is a 'sterile' environment. It was argued that the difficulty of culturing microbes from the blood was coming from the limited understanding of suitable growth/isolation media for the microbes to be cultured. This limitation can be overcome by the sequenced-based methods for detecting non-proliferating microbes. The presence of microbes in blood also can be observed by ultrastructural (microscopic) methods. Through the microscopic observations, it was witnessing the presence of coccus and bacillus shaped bacteria that present proximity to (Red Blood Cell) RBCs in sample blood patients with Alzheimer's or Parkinson's Disease. The presence of microbes in the places other than their normal location state by term 'atopobiosis'. The presence of microbes in blood suspected as a result of translocation between the gut to the blood.

Therefore, according to the current knowledge of microbiome association and the human diseases, we are eager to conduct a pilot project that gives a comprehensive picture of the association between the microbiome and uveitis disease partially non-infectious and idiopathic uveitis. We will investigate microbiome profiling in the intestinal and extra-intestinal of uveitis patients before and after treatment to see whether any alteration of microbial abundance at two distinct clinical conditions partially in uveitis patients with history of autoimmune disease (Behcet and Vogt-Koyanagi-Harada) and idiopathic uveitis. Another objective of this study is to explore any pathogenic microorganism that present in uveitis patients samples conducted by a sequenced-based method.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date July 30, 2020
Est. primary completion date July 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- New patient registered at Cipto Mangunkusumo Hospital since November 2019

- Patient diagnosed with non-infectious uveitis (with Behcet, VKH history)

- Patient idiopathic uveitis (proven to have negative result by available etiological uveitis work-ups)

- Minimum age: 18 years old

- Experience active inflammation in the past 180 days and or during patient registration following Standard Uveitis Nomenclature (SUN) guidelines, in at least:

- equal and or more than 2+ anterior chamber cells

- equal and or more than 2+ vitreous haze and/or

- active retinal/choroidal lesions

Exclusion Criteria:

- patients had taken probiotics supplement or antibiotics 3 months before sample collection

- or who experience prolonged diarrhea or constipation

- or undergone gastrointestinal surgery

- having any form of malignancy

- having a systemic disease such as hypertension, obesity, inflammatory bowel disease, or diabetes.

- Disagree to sign informed consent

- Uveitis is proven to be an infectious origin

- Pregnant patient

- Loss to follow up patient

Healthy volunteers are recruited for this study after giving consent with the following inclusion criteria:

- age: 18-50 years old (Man/Woman)

- having no health complaints or symptoms

- not in any long term medications

- having no history of allergy

- willing to cooperate in the study

- state of complete physical, mental and social well being

Study Design


Locations

Country Name City State
Indonesia RSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital) Jakarta Pusat Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Fakultas Kedokteran Universitas Indonesia

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Differential abundant taxonomic groups bacterial The primer used in this amplicon study is targeted to 16S rRNA gene region V3-V4 to detect bacterial diversity in the samples. The sequencing will be generated by Illumina according to standard protocol. Prior filter is conducted using Prinseq-lite, then chimeric sequences remove using Usearch61 and left over the high quality reads. The (operational taxonomic unit) OTU is picked using bioinformatic tool (Quantitative Insights Into Microbial Ecology - QIIME). Taxonomic classification for de novo OTUs clustering will be generated using open source software package for bioinformatics data processing. Shanon diversity, Simpson index will be examined for calculating alpha diversity. And then we will do identification of differential abundant taxonomic groups. And do analysis correlation network between bacterial genera among two clinical condition (before and after received oral steroid) relatively to health control. 0, 6 weeks
Secondary Detection pathogenic microorganism in samples In this study we are going to use IDseq Portal, a novel bioinformatics platform that designed for detection of microbes from metagenomic data. This analysis will be applied in all types samples (stool, blood, and aqueous humor). We expect to find any specific microbiome (bacterial/fungal/virus) signature in samples patient uveitis. 0, 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04528082 - Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease Phase 3
Recruiting NCT04101604 - Biomarkers of Common Eye Diseases
Terminated NCT04609397 - A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease Phase 2
Not yet recruiting NCT05128357 - IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease)
Recruiting NCT05879419 - Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Phase 4
Completed NCT03209219 - Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis Phase 3
Completed NCT04386824 - Erectile Dysfunction in Patients With Non Ocular Behçet's Disease
Completed NCT02648581 - Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease Phase 2
Recruiting NCT06451575 - Thrombophilia and Thrombosis in Behçet's Disease
Recruiting NCT04530461 - Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
Not yet recruiting NCT06386744 - Dusquetide for the Treatment of Behcet's Disease Phase 2
Recruiting NCT04334031 - Deployment o the Multidisciplinary Prospective Cohort Imminent N/A
Not yet recruiting NCT04105439 - Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
Not yet recruiting NCT05715294 - The Effect of Music on Sleep Quality in Behçet's Patients N/A
Active, not recruiting NCT06266247 - How Sirtuin Levels Change During Behçet Disease N/A
Recruiting NCT04959435 - Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
Recruiting NCT03837236 - Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease N/A
Recruiting NCT03803462 - Behçet's Disease Overall Damage Index